Profile
ABVC VRTX REGN SGEN ALNY ARGX
Company Name ABVC BioPharma, Inc. Vertex Pharmaceuticals Incorporated Regeneron Pharmaceuticals, Inc. Seagen Inc. Alnylam Pharmaceuticals, Inc. argenx SE
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology
Market Cap $13.49M $130.72B $60.54B $43.15B $35.25B $34.28B
Employees 0.02K 6.10K 15.11K 3.26K 2.23K 1.60K
CEO Dr. Uttam Yashwant Patil Ph.D. Dr. Reshma Kewalramani FASN, M.D. Dr. Leonard S. Schleifer M.D., Ph.D. Mr. David R. Epstein B.Sc., M.B.A. Dr. Yvonne L. Greenstreet M.B.A., M.D. Mr. Timothy Van Hauwermeiren EMBA, M.Sc.
Ratings
ABVC VRTX REGN SGEN ALNY ARGX
Quant Rating Score 1 2 4 3 1 3
Quant Rating Strong Sell Sell Buy Neutral Strong Sell Neutral
Trading
ABVC VRTX REGN SGEN ALNY ARGX
Last Close $0.855 $489.1 $563.16 $228.74 $234.56 $596.2
High 52 $1.59 $516.74 $1201.76 $228.74 $296.75 $671.75
Low 52 $0.41 $392.81 $546.39 $228.74 $143.31 $356.01
Price vs. 52 Week High -46.23 % -5.35 % -53.14 % 0 % -20.96 % -11.25 %
Price vs. 52 Week Low 108.54 % 24.51 % 3.07 % 0 % 63.67 % 67.47 %
Total Return
ABVC VRTX REGN SGEN ALNY ARGX
1 Month Return 29.96 % -4.52 % -15.34 % 0 % -3.99 % -2.45 %
3 Month Return 58.33 % 15.9 % -17.37 % 0 % -4.75 % -6.92 %
6 Month Return 56.02 % 1.26 % -43.15 % 0 % -20.74 % 5.52 %
9 Month Return -4.43 % 0.2 % -47.23 % 0 % -0.9 % 27.79 %
YTD Return 44.92 % 21.46 % -20.94 % 0 % -0.32 % -3.06 %
1 Year Return -18.57 % 24.3 % -37.01 % 0 % 61.59 % 66.35 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
ABVC VRTX REGN SGEN ALNY ARGX
Dividend Yield Percentage (TTM) - - 0.16 % - - -
Dividend Paid and Capex Coverage Ration (TTM) -89.92 % -1.65 % 5.37 % -2.27 % -0.24 % -44.32 %
Dividend Per Share (TTM) - - 0.88 % - - -
Payout Ratio (TTM) - - - - - -
Growth
ABVC VRTX REGN SGEN ALNY ARGX
Asset Growth 47.05 % -0.87 % 14.15 % -1.21 % 10.71 %
Gross Profit Growth -121.89 % 10.25 % 8.23 % 22.93 % 26.81 %
Revenue Growth -84.28 % 11.66 % 8.27 % 24.65 % 22.97 %
Revenue 3 Year -85.65 % 45.6 % -13.44 % 91.56 % 145.29 %
Revenue 5 Year 486.65 % 163.93 % 82.78 % 215.48 % 769.33 %
Revenue 10 Year - 1632.15 % 429.43 % 494.04 % 2468.51 %
EBIT Growth 45.64 % -105.41 % -1.39 % 10.13 % 37.31 %
Net Income Growth 35.54 % -114.8 % 11.61 % 9.51 % 36.82 %
Net Income 3 Yeari Growth Per Share 54.86 % -122.89 % -46.47 % -763.59 % 69.96 %
Net Income 5 Yeari Growth Per Share 31.36 % -145.38 % 111.07 % -276.93 % 73.33 %
Net Income 10 Yeari Growth Per Share -558.32 % 33.84 % 1232.49 % -624.16 % 55.42 %
Operating Income Growth 45.64 % -105.41 % -1.39 % 10.13 % 37.31 %
Operating Cash Flow Growth (CFG) 42.75 % -113.93 % -3.78 % 9.07 % -107.98 %
Operating 3 Year CFG 57.8 % -118.65 % -38.85 % -147.99 % 98.81 %
Operating 5 Year CFG -79.94 % -131.3 % 84.11 % -195.86 % 97.46 %
Operating 10 Year CFG -115.89 % 12.43 % 517.51 % -2622.09 % 97.1 %
EPS Growth 52.82 % -114.8 % 10.39 % 10.81 % 38.64 %
EPS Diluted Growth 52.82 % -114.97 % 10.27 % 10.81 % 38.64 %
Book Value Per Share 64.24 % -6.59 % 11.76 % -9.83 % 129.53 %
Share Holder 3 Year Equity Growth Per Share 10.93 % 62.6 % 53.21 % 33.72 % -89.49 %
Share Holder 5 Year Equity Growth Per Share 139.06 % 168.85 % 167.88 % 220.81 % -96.04 %
Share Holder 10 Year Equity Growth Per Share -98.8 % 1265.7 % 1113.59 % 691.19 % -95.86 %
Dividend Per Share Growth - - - - -
Dividend 3 Year Growth Per Share - - - - -
Dividend 5 Year Growth Per Share - - - - -
Dividend 10 Year Growth Per Share - - - - -
Debt Growth -25.43 % 116.42 % 0.06 % -23.28 % -51.69 %
Free Cash Flow Growth 43.38 % -124.1 % -0.08 % 3.67 % -201.54 %
Updated On 31 Dec 2023 31 Dec 2024 31 Dec 2024 31 Dec 2022 31 Dec 2024
Profitability
ABVC VRTX REGN SGEN ALNY ARGX
Gross Profit Margin TTM 70.8 % 86.09 % 84.47 % 72.37 % 85.62 % 46.33 %
Return on Assets TTM -57 % -2.38 % 11.69 % -11.76 % -6.56 % 13.45 %
Return on Equity TTM -98.4 % -3.28 % 14.77 % -16.53 % 905.33 % 16.83 %
Return on Capital Employed TTM -77.73 % -1.3 % 10.89 % -16.87 % -5.79 % -0.31 %
Net Income Per EBT TTM 95.26 % -215.53 % 92.32 % 100.55 % 73.71 % 25990.14 %
EBT Per Ebit TTM 136.64 % -100.69 % 118.85 % 94.01 % 213.34 % -18.79 %
EBIT Per Revenue TTM -1242.22 % -2.24 % 28.32 % -36.09 % -7.87 % -0.77 %
Cash Flow To Debt Ratio TTM -81.95 % -28.16 % 222.76 % -185.98 % -0.64 % -201.37 %
Receivables Turnover TTM 0.42 6.84 2.29 1.98 5.55 2.46
Payables Turnover TTM - 3.71 2.79 1.54 3.66 1.83
Inventory Turnover TTM - 1.27 0.71 0.65 4.12 2.93
Fixed Asset Turnover TTM 6.04 % 425.82 % 308.76 % 256.83 % 323.99 % 5106.8 %
Asset Turnover TTM 3.52 % 48.84 % 37.61 % 34.46 % 53.02 % 35.83 %
Operating Cash Flow Per Share TTM -0.15 -1.91 41.08 -1.12 -0.06 -1.07
Free Cash Flow Per Share TTM -0.15 -3.07 33.43 -1.62 -0.33 -1.09
Cash Per Share TTM 1.68 % 2375.11 % 16647.4 % 657.5 % 2095.42 % 4597.04 %
Operating Cash Flow Sales Ratio TTM -373.95 % -4.48 % 31.13 % -16.85 % -0.37 % -3.54 %
Free Cash Flow Operating Cash Flow Ratio TTM 98.89 % 160.43 % 81.38 % 144.14 % 512.38 % 102.26 %
Cash Flow Coverage Ratios TTM -81.95 % -28.16 % 222.76 % -185.98 % -0.64 % -201.37 %
Price To Free Cash Flows Ratio TTM -7.16 -165.4 16.83 -141.85 -827.74 -444.85
Price To Operating Cash Flows Ratio TTM -5.56 -266.09 13.71 -203.89 -4192.79 -531.16
Price Cash Flow Ratio TTM -5.56 -266.09 13.71 -203.89 -4192.79 -531.16
Income Statement (TTM)
ABVC VRTX REGN SGEN ALNY ARGX
Revenue $0B $11.02B $14.2B $1.96B $2.25B $2.19B
Gross Profit $0B $9.49B $12.23B $1.55B $1.92B $1.96B
Gross Profit Ratio 100% 86.11% 86.13% 79.1% 85.62% 89.62%
EBITDA $0B $0.49B $5.32B $-0.62B $-0.18B $0B
Net Income $-0.01B $-0.54B $4.41B $-0.61B $-0.28B $0.83B
EPS Diluted - -2.08 38.34 -3.3 -2.16 12.78
Balance Sheet (MRQ)
ABVC VRTX REGN SGEN ALNY ARGX
Long Term Debt $0B $1.66B $2.7B $0.04B $0B $0.03B
Total Liabilities $0.01B $6.12B $8.41B $0.87B $4.17B $0.68B
Total Equity $0B $16.41B $29.35B $2.8B $0.07B $5.31B
Total Investments $0B $6.65B $6.52B $1.42B $1.73B $1.82B
Total Debt $0B $1.75B $2.7B $0.04B $1.3B $0.04B
Total Assets $0.01B $22.53B $37.76B $3.67B $4.24B $5.99B
Cash Flow Statement (TTM)
ABVC VRTX REGN SGEN ALNY ARGX
Net Income $0B $-0.54B $4.41B $-0.61B $-0.28B $0.8B
Inventory $0B $-0.52B $-0.62B $-0.23B $0.01B $-0.09B
Dividends Paid $0B $0B $0B $0B $0B $0B
Operating Cash Flow $0B $-0.49B $4.42B $-0.45B $-0.01B $-0.08B
Capital Expenditure $0B $-0.3B $-0.76B $-0.08B $-0.03B $-0B
Related Stocks
Ticker Name Price
AADI Aadi Bioscience, Inc. 2.05
AAPG 18.72
ABCL AbCellera Biologics Inc. 2.42
ABCM Abcam plc 23.99
ABEO Abeona Therapeutics Inc. 4.84
ABIO ARCA biopharma, Inc. 28.8
ABOS Acumen Pharmaceuticals, Inc. 0.9008
ABPWW 0.0465
ABSI Absci Corporation 3.09
ABUS Arbutus Biopharma Corporation 3.15
ABVX Abivax SA American Depositary Shares 6.4
ACAD ACADIA Pharmaceuticals Inc. 14.73
ACER Acer Therapeutics Inc. 0.6601
ACET Adicet Bio, Inc. 0.5258
ACGN Aceragen, Inc. 0.3849
ACHL Achilles Therapeutics plc 1.48
ACHV Achieve Life Sciences, Inc. 1.99
ACIU AC Immune SA 1.48
ACLX Arcellx, Inc. 62.02
ACRV Acrivon Therapeutics, Inc. Common Stock 1.81
ETFs With Exposure to ABVC
Ticker ETF Name Weight Percentage Price
VTI Vanguard Total Stock Market Index Fund 0 258.75
VXF Vanguard Extended Market Index Fund 0 161.89
IWC iShares Micro-Cap ETF 0 104.56
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0 122.89
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0 122.9
VEMPX Vanguard Extended Market Index InstlPlus 0 303.28
Unlock